L5WPhase Holographic Imaging PHI ABL5W info
$0.46info-0.24%24h
Global rank32102
Market cap$9.26M
Change 7d1.21%
YTD Performance-15.69%
SP500 benchmarkUnderperform
P/E-0.40
P/S9.72
Revenue$953.09K
Earnings-$2.23M
Dividend yield-
Main Sector
Healthcare

Phase Holographic Imaging PHI AB (L5W) Stock Overview

Phase Holographic Imaging PHI AB (publ) develops and markets instrumentation for non-invasive time-lapse imaging in Sweden and internationally. The company's products include HoloMonitor M4, a live cell imaging microscope system; HoloMonitor M3, a bench-top time-lapse cytometer equipped with a motorized stage and variable magnification; HoloMonitor app Suite for cell imaging software facilitates kinetic live-cell tracking and analysis; HoloMonitor M4FL, a system for fluorescence; and HoloMonitor single tracking, kinetic dose response and cell mobility, cell morphology, wound healing, cell quality control, cell control, and kinetic cell proliferation assay. It offers HoloLids to eliminate image disturbances caused by surface vibrations and condensation inside the cell culture vessel; Vessel Holder to fix the culture vessel to the motorized stage; and HoloDry to keep optics for condensation of HoloMonitor free. Its products are used in cancer research, drug discovery and development, single cell analysis, cell counting, cell quality check, counting, proliferation, motility, migration, morphology, and tracking, as well as dose responses and wound healing. The company was incorporated in 1997 and is based in Lund, Sweden.

L5W Stock Information

Symbol
L5W
Address
SkiffervAegen 48Lund, 224 78Sweden
Founded
-
Trading hours
-
Website
https://www.phiab.se
Country
πŸ‡ΈπŸ‡ͺ Sweden
Phone Number
46 46 38 60 80

Phase Holographic Imaging PHI AB (L5W) Price Chart

-
Value:-

Phase Holographic Imaging PHI AB Overview: Key Details and Summary

Stock data
2023
Change
Price
$0.46142833544408346
N/A
Market Cap
$9.26M
N/A
Shares Outstanding
20.07M
39.43%
Employees
13.00
N/A
Shareholder Equity
3.73M
-86.18%
Valuation
2023
Change
P/E Ratio
-0.40
N/A
P/S Ratio
9.72
N/A
P/B Ratio
2.48
N/A
Growth
2023
Change
Return on Equity
-0.5987
N/A
Earnings
2023
Change
Revenue
$953.09K
N/A
Earnings
-$2.23M
N/A
EPS
-1.16
N/A
Earnings Yield
-2.51
N/A
Gross Margin
0.5119
N/A
Operating Margin
-2.06
N/A
Net income margin
-2.34
N/A
Financial Strength
2023
Change
Total Assets
$3.34M
N/A
Total Debt
$2.16M
N/A
Cash on Hand
$511.01K
N/A
Debt to Equity
0.8000
630.42%
Cash to Debt
0.2367
319.32%
Current Ratio
$1.39
-74.92%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
Β© 2024 Topstocks.org